Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
85 participants
OBSERVATIONAL
2020-09-27
2021-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Left Atrial Appendage Occlusion Registry (LAAO Registry)
NCT02699957
Comparison of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients in AF Undergoing TAVI
NCT03088098
Left Atrial Appendage Occlusion in Patients With Non-valvular Atrial Fibrillation From Shanghai
NCT03987945
Association Between S-LAAO and Adverse Cardiovascular Events Among Patients Undergoing Coronary Artery Bypass Grafting.
NCT04108169
LAAO With DAPT Versus Antithrombotic Therapy
NCT03310801
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
If significant leaks are present, patients usually remain on oral anticoagulation. In very few cases, an interventional approach is used to close peri-device leaks.
This is the first systematic study, trying to include a respectable number of patients who underwent peri-device leakage closure after LAAO. In this multi-center, collaborative study the investigators aim to identify different peri-device leak closure strategies with associated clinical outcomes and evaluate safety and feasibility of the procedure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
significant peri-device leakage after LAA occlusion
Peri-device leakage closure after left atrial appendage occlusion
Peri-device leakage closure after left atrial appendage occlusion
Peri-device leakage closure after left atrial appendage occlusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peri-device leakage closure after left atrial appendage occlusion
Peri-device leakage closure after left atrial appendage occlusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cardiovascular Center Frankfurt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kerstin Piayda
Role: STUDY_CHAIR
University Hospital Düsseldorf and Cardio Vascular Center Frankfurt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
• Banner University Medical Center Phoenix
Phoenix, Arizona, United States
Scripps Health
La Jolla, California, United States
Kansas City Heart Rhythm Institute
Overland Park, Kansas, United States
Mayo Clinic Hospital - Saint Mary's Campus
Rochester, Minnesota, United States
Vanderbilt Heart Institute
Nashville, Tennessee, United States
Austin Heart
Austin, Texas, United States
University of Utah Hospital
Salt Lake City, Utah, United States
Aarhus University Hospital
Aarhus, , Denmark
Rigshospitalet Copenhagen
Copenhagen, , Denmark
Cardio Vascular Center Frankfurt
Frankfurt am Main, Hesse, Germany
Universitätsklinikum Düsseldorf
Düsseldorf, North Rhine-Westphalia, Germany
Universitätsmedizin Berlin - Campus Benjamin Franklin (CBF)
Berlin, , Germany
Poznan University of Medical Sciences
Poznan, , Poland
Hospital Universitario de Salamanca
Salamanca, , Spain
Inselspital Bern
Bern, , Switzerland
Nuffield Health
Headington, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CVC-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.